Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CX-5461, a selective inhibitor of rRNA synthesis, suppresses Pol I-driven transcription of rRNA.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 35.00 | |
2 mg | In stock | $ 47.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 163.00 | |
25 mg | In stock | $ 291.00 | |
50 mg | In stock | $ 492.00 | |
100 mg | In stock | $ 717.00 | |
500 mg | In stock | $ 1,470.00 |
Description | CX-5461, a selective inhibitor of rRNA synthesis, suppresses Pol I-driven transcription of rRNA. |
Targets&IC50 | Pol I-driven transcription of rRNA:142 nM |
In vitro | CX-5461 demonstrates the capacity to inhibit cell proliferation in various cell lines, notably HCT-116 (EC50=167 nM), A375 (EC50=58 nM), and MIA PaCa-2 (EC50=74 nM). In solid tumor cells, CX-5461 induces autophagy or senescence rather than apoptosis. For instance, in melanoma A375 cells and pancreatic cancer MIA PaCa-2 cells, its effects are quantified with Pol I IC50 values of 113 nM and 54 nM, respectively, while showing significantly less effect on Pol II (Pol II IC50 > 25 μM for A375 and ~25 mM for MIA PaCa-2). Furthermore, in HCT-116 cells, CX-5461 selectively inhibits rRNA synthesis, with an observed Pol I IC50 of 142 nM and minimal impact on Pol II (IC50 > 25 μM). |
In vivo | In a mouse model of xenograft human solid tumors, oral administration of CX-5461 (50 mg/kg) demonstrated antitumor activity against solid tumors. |
Kinase Assay | Pol I and Pol II Transcription Assay: Two short-lived RNA transcripts (half-lives ~20-30 minutes), one produced by Pol I and another by Pol II, are quantitated by qRT-PCR as a measure of CX-5461-related effects on transcription. The 45S pre-rRNA served as the Pol I transcript and the mRNA for the protooncogene c-myc served as the comparator Pol II transcript. Both Pol I and Pol II transcription are known to be affected by general cellular stress. To minimize the potential effects of such stress, cells are exposed to test agents for only a short period of time (2 hours). This is sufficient time for these transcripts to be reduced by greater than 90% if CX-5461 affects their synthesis. |
Cell Research | Cells are plated on 96-well plates and treated the next day with dose response of CX-5461 for 96 hours. Cell viability is determined using Alamar Blue and CyQUANT assays(Only for Reference) |
Molecular Weight | 513.61 |
Formula | C27H27N7O2S |
CAS No. | 1138549-36-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: < 1 mg/mL
H2O: 5.1 mg/mL (10 mM), when pH is adjusted to 7 with HCl. Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CX-5461 1138549-36-6 Cell Cycle/Checkpoint DNA Damage/DNA Repair DNA/RNA Synthesis Inhibitor CX 5461 CX5461 inhibit inhibitor